Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphomannomutase 2 pseudogene 2 (PMM2P2) is a processed pseudogene in the human genome related to the functional gene PMM2 on chromosome 16. As a pseudogene, it does not produce an active enzyme or protein and has no known biological function, clinical implications, or drug interactions. It is distinct from PMM2, which encodes an essential enzyme for glycosylation[1][11]. PMM2P2 should not be confused with PMM2, the enzyme phosphomannomutase 2, which is associated with congenital disorders of glycosylation and clinical disease, and is a valid therapeutic target[4][7][12]. PMM2P2, as a pseudogene, lacks protein-coding capacity and clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphomannomutase 2 pseudogene 2 (PMM2P2).